ARTICLE SUMMARY:
Coridea's founders on their first-gear approach for translating back of the napkin ideas into novel therapeutics; IVL start-ups poised to play with the giants in a competitive field; Vensana Capital closes its third fund; learning goes both ways for the strategics that mentor MedTech Innovator start-ups; Cleerly and Bunkerhill team up on identifying cardiac risk; plus profiles of GrayMatters Health and Lattice Medical.
